446 related articles for article (PubMed ID: 19390056)
1. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
Brock M; Trenkmann M; Gay RE; Michel BA; Gay S; Fischler M; Ulrich S; Speich R; Huber LC
Circ Res; 2009 May; 104(10):1184-91. PubMed ID: 19390056
[TBL] [Abstract][Full Text] [Related]
2. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
[TBL] [Abstract][Full Text] [Related]
4. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
8. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
[TBL] [Abstract][Full Text] [Related]
9. Interplay between microRNAs and the STAT3 signaling pathway in human cancers.
Cao Q; Li YY; He WF; Zhang ZZ; Zhou Q; Liu X; Shen Y; Huang TT
Physiol Genomics; 2013 Dec; 45(24):1206-14. PubMed ID: 24192393
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2.
Zeng Y; Qu X; Li H; Huang S; Wang S; Xu Q; Lin R; Han Q; Li J; Zhao RC
FEBS Lett; 2012 Jul; 586(16):2375-81. PubMed ID: 22684006
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
Gong J; Zhang JP; Li B; Zeng C; You K; Chen MX; Yuan Y; Zhuang SM
Oncogene; 2013 Jun; 32(25):3071-9. PubMed ID: 22824797
[TBL] [Abstract][Full Text] [Related]
12. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
[TBL] [Abstract][Full Text] [Related]
13. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling.
Xiao Y; Wang J; Yan W; Zhou Y; Chen Y; Zhou K; Wen J; Wang Y; Cai W
J Hepatol; 2015 Apr; 62(4):889-96. PubMed ID: 25450715
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin enhances bone morphogenetic protein receptor type II expression.
Hu H; Sung A; Zhao G; Shi L; Qiu D; Nishimura T; Kao PN
Biochem Biophys Res Commun; 2006 Jan; 339(1):59-64. PubMed ID: 16297860
[TBL] [Abstract][Full Text] [Related]
16. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.
Wei Y; Nazari-Jahantigh M; Chan L; Zhu M; Heyll K; Corbalán-Campos J; Hartmann P; Thiemann A; Weber C; Schober A
Circulation; 2013 Apr; 127(15):1609-19. PubMed ID: 23513069
[TBL] [Abstract][Full Text] [Related]
18. The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma.
Ohno M; Natsume A; Kondo Y; Iwamizu H; Motomura K; Toda H; Ito M; Kato T; Wakabayashi T
Mol Cancer Res; 2009 Dec; 7(12):2022-30. PubMed ID: 19934272
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
